• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KARL STORZ ENDOSCOPY-AMERICA INC. UNIDRIVE; LAPAROSCOPE, GYNECOLOGIC (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KARL STORZ ENDOSCOPY-AMERICA INC. UNIDRIVE; LAPAROSCOPE, GYNECOLOGIC (AND ACCESSORIES) Back to Search Results
Model Number 20711120
Device Problem Insufficient Information (3190)
Patient Problem Cancer (3262)
Event Date 10/07/2013
Event Type  Injury  
Event Description
A total laparoscopic hysterectomy with morcellation of presumed uterine fibroids was performed.The patient was later found to have uterine leiomyosarcoma (via pathology) with evidence of metastasis 5 months after surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNIDRIVE
Type of Device
LAPAROSCOPE, GYNECOLOGIC (AND ACCESSORIES)
Manufacturer (Section D)
KARL STORZ ENDOSCOPY-AMERICA INC.
2151 e. grand avenue
el segundo CA 90245
MDR Report Key5418687
MDR Text Key37732244
Report Number5418687
Device Sequence Number1
Product Code HET
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 01/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2016
Is this an Adverse Event Report? Yes
Device Operator Physician
Device Model Number20711120
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/04/2016
Event Location Hospital
Date Report to Manufacturer01/04/2016
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
NO
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age40 YR
-
-